Evidence map›Paper›PMID 30753537›Full record

ArticleJournal of molecular cell biology2019

ADAM10 sheddase activation is controlled by cell membrane asymmetry.

Florian Bleibaum, Anselm Sommer, Martin Veit, Björn Rabe, Jörg Andrä, Karl Kunzelmann, Christian Nehls, Wilmar Correa, Thomas Gutsmann, Joachim Grötzinger and 2 more

Abstract read
In one paragraph

Article in Journal of molecular cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lipid-Facilitated Opening of the ADAM10 Sheddase Revealed by Enhanced Sampling Simulations.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Florian BleibaumDepartment of Dermatology, University of Kiel, Kiel, Germany.
Anselm SommerDepartment of Dermatology, University of Kiel, Kiel, Germany.
Martin VeitDepartment of Dermatology, University of Kiel, Kiel, Germany.
Björn RabeInstitute of Biochemistry, University of Kiel, Olshausenstraße 40, Kiel, Germany.
Jörg AndräHamburg University of Applied Science, Ulmenliet 20, Hamburg, Germany.
Karl KunzelmannPhysiological Institute, University of Regensburg, Universitätsstraße 31, Regensburg, Germany.
Christian NehlsForschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, Borstel, Germany.
Wilmar CorreaForschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, Borstel, Germany.
Thomas GutsmannForschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 10, Borstel, Germany.
Joachim GrötzingerInstitute of Biochemistry, University of Kiel, Olshausenstraße 40, Kiel, Germany.
Sucharit BhakdiDepartment of Dermatology, University of Kiel, Kiel, Germany.
Karina ReissDepartment of Dermatology, University of Kiel, Kiel, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of the disintegrin-metalloproteinase ADAM10 may contribute to the development of diseases including tumorigenesis and Alzheimer's disease. The mechanisms underlying ADAM10 sheddase activation are incompletely understood. Here, we show that transient exposure of the negatively charged phospholipid phosphatidylserine (PS) is necessarily required. The soluble PS headgroup was found to act as competitive inhibitor of substrate cleavage. Overexpression of the Ca2+-dependent phospholipid scramblase Anoctamin-6 (ANO6) led to increased PS externalization and substrate release. Transfection with a constitutively active form of ANO6 resulted in maximum sheddase activity in the absence of any stimulus. Calcium-dependent ADAM10 activation could not be induced in lymphocytes of patients with Scott syndrome harbouring a missense mutation in ANO6. A putative PS-binding motif was identified in the conserved stalk region. Replacement of this motif resulted in strong reduction of sheddase activity. In conjunction with the recently described 3D structure of the ADAM10 extracellular domain, a model is advanced to explain how surface-exposed PS triggers ADAM10 sheddase function.

Indexed as

Enzyme ActivationADAM10 ProteinAmino Acid SequenceAnimalsAnoctaminsBiomarkersCell LineCell MembraneChlorocebus aethiopsCOS CellsErythrocytesHumansMembrane ProteinsModels, BiologicalPhosphoserineRabbitsADAM10 ProteinAnoctaminsBiomarkersMembrane ProteinsPhosphoserineactivationADAM10Anoctamin-6cell membrane asymmetryphosphatidylserineshedding

Identifiers

PMID30753537
PMCPMC6927242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.